EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
Open Access
- 30 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 123 (6), 942-954
- https://doi.org/10.1038/s41416-020-0943-2
Abstract
Background The activation of the EGFR/Ras-signalling pathway in tumour cells induces a distinct chemokine repertoire, which in turn modulates the tumour microenvironment. Methods The effects of EGFR/Ras on the expression and translation of CCL20 were analysed in a large set of epithelial cancer cell lines and tumour tissues by RT-qPCR and ELISA in vitro. CCL20 production was verified by immunohistochemistry in different tumour tissues and correlated with clinical data. The effects of CCL20 on endothelial cell migration and tumour-associated vascularisation were comprehensively analysed with chemotaxis assays in vitro and in CCR6-deficient mice in vivo. Results Tumours facilitate progression by the EGFR/Ras-induced production of CCL20. Expression of the chemokine CCL20 in tumours correlates with advanced tumour stage, increased lymph node metastasis and decreased survival in patients. Microvascular endothelial cells abundantly express the specific CCL20 receptor CCR6. CCR6 signalling in endothelial cells induces angiogenesis. CCR6-deficient mice show significantly decreased tumour growth and tumour-associated vascularisation. The observed phenotype is dependent on CCR6 deficiency in stromal cells but not within the immune system. Conclusion We propose that the chemokine axis CCL20–CCR6 represents a novel and promising target to interfere with the tumour microenvironment, and opens an innovative multimodal strategy for cancer therapy.Keywords
Funding Information
- Austrian Science Fund (I4300-B, W1212, W1212)
- Vienna Science and Technology Fund (LS16-025)
- European Research Council (ERC) advanced grant
- Deutsche Forschungsgemeinschaft (SPP1190, HO 2092/8-1)
This publication has 48 references indexed in Scilit:
- Modeling the Transcriptional Consequences of Epidermal Growth Factor Receptor Ablation in Ras-Initiated Squamous CancerClinical Cancer Research, 2012
- Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease ProgressionPLOS ONE, 2011
- EGFR and IL-1 Signaling Synergistically Promote Keratinocyte Antimicrobial Defenses in a Differentiation-Dependent MannerJournal of Investigative Dermatology, 2011
- CCL20/CCR6 expression profile in pancreatic cancerJournal of Translational Medicine, 2010
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitroInternational Journal of Cancer, 2008
- Tumor immune escape by the loss of homeostatic chemokine expressionProceedings of the National Academy of Sciences of the United States of America, 2007
- The EGF receptor is required for efficient liver regenerationProceedings of the National Academy of Sciences of the United States of America, 2007
- Inflammation and cancerNature, 2002
- The Hallmarks of CancerCell, 2000